Diseases (12)
Diagnostic Testing (12)

Note: Reflex to culture if elevated WBC and no crystals or bacteria are seen.

Note: If joined inflammation and aspiration required.

Note: If arthritis present

Note: If joints are involved.

Note: If arthritis present are involved.

Note: If obtained, the synovial fluid in Neuropathic arthropathy is clear, sterile and lack crystals.

Overview

Synovial fluid analysis is utilized to diagnose the cause of pain, swelling, and fluid collection in the joints. The joints that are most commonly affected are the knee, hip, and shoulder joints. The conditions that affect the synovial fluid can be broken down into five general categories. These disease categories are Non-Inflammatory disease, Inflammatory disease, Infectious disease, Degenerative disease, and Bleeding disorders. Non-inflammatory diseases that are associated with synovial fluid involvement include trauma, sickle cell disease, and CPPD crystal deposition disease (pseudogout). Inflammatory diseases associated with synovial fluid include autoimmune disorders such as systemic lupus erythematosus, psoriasis, and rheumatoid arthritis as well as gout. Infectious arthritis is usually acute bacterial in nature. The most common causative organism in some studies is Neisseria gonnorrhea following by Staphylococcus aureus. Chronic septic arthritis is rare and reported causative organisms include Mycobacterium tuberculosis and Candida albicans. Bleeding disorders that lead to blood in the synovial fluid typically involve individuals with blood clotting disorders such as hemophilia, von Willenbrand’s disease, Glanzmann’s thrombasthenia, and synovial tumors as well as injuries. Degenerative disorders include primarily osteoarthritis which causes erosion of the joint surfaces and accumulation of fibrin.

The most important reason to perform an analysis on synovial fluid is to rule out septic arthritis. Analysis of synovial fluid is rarely needed in pediatric patients, but is used primarily to differentiate between inflammatory and non-inflammatory disease states. Analysis of synovial fluid usually includes multiple studies such as cell count, microscopic analysis, culture, examination for crystals, and other chemical analysis.

Clinical Utility

  • Diagnosis of joint disease such as gout and traumatic arthritis
  • Differential diagnosis of traumatic arthritis from the immune-based and crystal-induced arthritis
  • As an aid in diagnosis of joint disease due to inflammation and infection
  • Aid in diagnosis of joint injury

Interpretation

Abnormal in:

  • Gout (uric acid)
  • Pseudogout (calcium pyrophosphate deposition disease)
  • Rheumatoid arthritis
  • Infectious arthritis (lactate dehydrogenase)
  • Immune-based arthritis
  • Bacterial infection (protein)
  • Joint injury
  • Lower than normal viscocity is associated with inflammation
  • Decreased clarity (cloudy SF) may indicate crystals, WBCs, or microorganisms in the fluid
  • Reddish SF indicates red blood cells in the fluid which can indicate bleeding disorders
  • Decreased glucose is associated with inflammation but compare with serum glucose

Reference Ranges

Parameter Normal Pathological Normal Pathological
Volume, mL (knee) <4 >4 <0.004 L >0.004 L
Viscosity
String test + (high) − (low)
Mucin clot Firm Friable
Clarity Clear Cloudy
Color Straw Red
Cell Counts
WBC (/µL) <200 >2000 <0.2 × 109/L >2 × 109/L
Percent of Total / Fraction of Total
PMN <25% >75% <0.25 >0.75
RBC <2% >50% <0.02 >0.50
Chemistry
Total protein 1.2–3.0 g/dL >4.0 g/dL 12–30 g/L >40 g/L
Glucose Serum level − <60 mg/dL Serum level − 3.4 mmol/L

Methodology
Visual examination, cell count and differential, polarizing microscopic exam for crystals, Gram stain, AFB smear and culture, Culture and susceptibility testing.

Specimen Collection

Synovial fluid aspirate. EDTA (Lavender) preferred, or Heparin (Green) acceptable.

  • Ideally 15 mL divided into two sodium heparin tubes and one sterile tube without additives.
  • Ambient: 48 hours
  • Refrigerated: 48 hours

Additional Testing

Blood/urine uric acid, Blood glucose, Joint bacterial mycobacterial and fungal cultures as indicated, Blood cultures if systemic infection is suspected, ANA, CBC with differential, ESR, C-reactive protein.

CPT
83872$5.86
84157$4
89051$5.6
89060$7.33

ICD10
  • AK - Alaska
  • AL - Alabama
  • AR - Arkansas
  • AS - American Samoa
  • AZ - Arizona
  • CA - California - Entire State
  • CO - Colorado
  • CT - Connecticut
  • DC - District of Columbia
  • DE - Delaware
  • FL - Florida
  • GA - Georgia
  • GU - Guam
  • HI - Hawaii
  • IA - Iowa
  • ID - Idaho
  • IL - Illinois
  • IN - Indiana
  • KS - Kansas
  • KY - Kentucky
  • LA - Louisiana
  • MA - Massachusetts
  • MD - Maryland
  • ME - Maine
  • MI - Michigan
  • MN - Minnesota
  • MO - Missouri - Entire State
  • MS - Mississippi
  • MT - Montana
  • NC - North Carolina
  • ND - North Dakota
  • NE - Nebraska
  • NH - New Hampshire
  • NJ - New Jersey
  • NM - New Mexico
  • NV - Nevada
  • NY - New York - Entire State
  • OH - Ohio
  • OK - Oklahoma
  • OR - Oregon
  • PA - Pennsylvania
  • PR - Puerto Rico
  • RI - Rhode Island
  • SC - South Carolina
  • SD - South Dakota
  • TN - Tennessee
  • TX - Texas
  • UT - Utah
  • VA - Virginia
  • VI - Virgin Islands
  • VT - Vermont
  • WA - Washington
  • WI - Wisconsin
  • WV - West Virginia
  • WY - Wyoming
  • CNMI - Northern Mariana Islands
  • EM - Missouri - Northeastern & Southern
  • WM - Missouri - Northwestern
  • DN - New York - Downstate
  • QN - New York - Queens
  • UN - New York - Upstate
  • NF - California - Northern
  • SF - California - Southern
Showing results for all states.
Filter:
ICD10 CODE AND DESCRIPTIONLCD CODENCD CODE
A01.05 - Typhoid osteomyelitis
A02.0 - Salmonella enteritis
A02.24 - Salmonella osteomyelitis
A03.9 - Shigellosis, unspecified
A04.5 - Campylobacter enteritis
A18.02 - Tuberculous arthritis of other joints
A18.03 - Tuberculosis of other bones
A41.01 - Sepsis due to Methicillin susceptible Staphylococcus aureus
A41.02 - Sepsis due to Methicillin resistant Staphylococcus aureus
A41.89 - Other specified sepsis
A41.9 - Sepsis, unspecified organism
A49.1 - Streptococcal infection, unspecified site
A54.42 - Gonococcal arthritis
A54.43 - Gonococcal osteomyelitis
A54.9 - Gonococcal infection, unspecified
A56.00 - Chlamydial infection of lower genitourinary tract, unspecified
A56.19 - Other chlamydial genitourinary infection
A68 - Relapsing fevers
A69.23 - Arthritis due to Lyme disease
A78 - Q fever
B95 - Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified elsewhere
B95.0 - Streptococcus, group A, as the cause of diseases classified elsewhere
B95.1 - Streptococcus, group B, as the cause of diseases classified elsewhere
B95.61 - Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere
B95.62 - Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere
B95.7 - Other staphylococcus as the cause of diseases classified elsewhere
B95.8 - Unspecified staphylococcus as the cause of diseases classified elsewhere
D57.1 - Sickle-cell disease without crisis
D64 - Other anemias
D64.9 - Anemia, unspecified
D84.9 - Immunodeficiency, unspecified
E08.610 - Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy
E09.610 - Drug or chemical induced diabetes mellitus with diabetic neuropathic arthropathy
E10.42 - Type 1 diabetes mellitus with diabetic polyneuropathy
E10.610 - Type 1 diabetes mellitus with diabetic neuropathic arthropathy
E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, unspecified
E11.42 - Type 2 diabetes mellitus with diabetic polyneuropathy
E11.51 - Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene
E11.610 - Type 2 diabetes mellitus with diabetic neuropathic arthropathy
E11.9 - Type 2 diabetes mellitus without complications
E13.610 - Other specified diabetes mellitus with diabetic neuropathic arthropathy
E79 - Disorders of purine and pyrimidine metabolism
E79.0 - Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
E79.9 - Disorder of purine and pyrimidine metabolism, unspecified
E85 - Amyloidosis
E85.9 - Amyloidosis, unspecified
F11 - Opioid related disorders
F11.20 - Opioid dependence, uncomplicated
F19 - Other psychoactive substance related disorders
F19.1 - Other psychoactive substance abuse

Additional ICD10
  • AK - Alaska
  • AL - Alabama
  • AR - Arkansas
  • AS - American Samoa
  • AZ - Arizona
  • CA - California - Entire State
  • CO - Colorado
  • CT - Connecticut
  • DC - District of Columbia
  • DE - Delaware
  • FL - Florida
  • GA - Georgia
  • GU - Guam
  • HI - Hawaii
  • IA - Iowa
  • ID - Idaho
  • IL - Illinois
  • IN - Indiana
  • KS - Kansas
  • KY - Kentucky
  • LA - Louisiana
  • MA - Massachusetts
  • MD - Maryland
  • ME - Maine
  • MI - Michigan
  • MN - Minnesota
  • MO - Missouri - Entire State
  • MS - Mississippi
  • MT - Montana
  • NC - North Carolina
  • ND - North Dakota
  • NE - Nebraska
  • NH - New Hampshire
  • NJ - New Jersey
  • NM - New Mexico
  • NV - Nevada
  • NY - New York - Entire State
  • OH - Ohio
  • OK - Oklahoma
  • OR - Oregon
  • PA - Pennsylvania
  • PR - Puerto Rico
  • RI - Rhode Island
  • SC - South Carolina
  • SD - South Dakota
  • TN - Tennessee
  • TX - Texas
  • UT - Utah
  • VA - Virginia
  • VI - Virgin Islands
  • VT - Vermont
  • WA - Washington
  • WI - Wisconsin
  • WV - West Virginia
  • WY - Wyoming
  • CNMI - Northern Mariana Islands
  • EM - Missouri - Northeastern & Southern
  • WM - Missouri - Northwestern
  • DN - New York - Downstate
  • QN - New York - Queens
  • UN - New York - Upstate
  • NF - California - Northern
  • SF - California - Southern
Showing results for all states.
Filter:
ICD10 CODE AND DESCRIPTIONLCD CODENCD CODE
A68.0 - Louse-borne relapsing fever
A68.1 - Tick-borne relapsing fever
A68.9 - Relapsing fever, unspecified
B95.0 - Streptococcus, group A, as the cause of diseases classified elsewhere
B95.1 - Streptococcus, group B, as the cause of diseases classified elsewhere
B95.2 - Enterococcus as the cause of diseases classified elsewhere
B95.3 - Streptococcus pneumoniae as the cause of diseases classified elsewhere
B95.4 - Other streptococcus as the cause of diseases classified elsewhere
B95.5 - Unspecified streptococcus as the cause of diseases classified elsewhere
B95.6 - Staphylococcus aureus as the cause of diseases classified elsewhere
B95.61 - Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere
B95.62 - Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere
B95.7 - Other staphylococcus as the cause of diseases classified elsewhere
B95.8 - Unspecified staphylococcus as the cause of diseases classified elsewhere
D64.0 - Hereditary sideroblastic anemia
D64.1 - Secondary sideroblastic anemia due to disease
D64.2 - Secondary sideroblastic anemia due to drugs and toxins
D64.3 - Other sideroblastic anemias
D64.4 - Congenital dyserythropoietic anemia
D64.8 - Other specified anemias
D64.81 - Anemia due to antineoplastic chemotherapy
D64.89 - Other specified anemias
D64.9 - Anemia, unspecified
E79.0 - Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
E79.1 - Lesch-Nyhan syndrome
E79.2 - Myoadenylate deaminase deficiency
E79.8 - Other disorders of purine and pyrimidine metabolism
E79.9 - Disorder of purine and pyrimidine metabolism, unspecified
E85.0 - Non-neuropathic heredofamilial amyloidosis
E85.1 - Neuropathic heredofamilial amyloidosis
E85.2 - Heredofamilial amyloidosis, unspecified
E85.3 - Secondary systemic amyloidosis
E85.4 - Organ-limited amyloidosis
E85.8 - Other amyloidosis
E85.81 - Light chain (AL) amyloidosis
E85.82 - Wild-type transthyretin-related (ATTR) amyloidosis
E85.89 - Other amyloidosis
E85.9 - Amyloidosis, unspecified
F11.1 - Opioid abuse
F11.10 - Opioid abuse, uncomplicated
F11.11 - Opioid abuse, in remission
F11.12 - Opioid abuse with intoxication
F11.120 - Opioid abuse with intoxication, uncomplicated
F11.121 - Opioid abuse with intoxication delirium
F11.122 - Opioid abuse with intoxication with perceptual disturbance
F11.129 - Opioid abuse with intoxication, unspecified
F11.13 - Opioid abuse with withdrawal
F11.14 - Opioid abuse with opioid-induced mood disorder
F11.15 - Opioid abuse with opioid-induced psychotic disorder
F11.150 - Opioid abuse with opioid-induced psychotic disorder with delusions

References

  • Best Pract Res Clin Rheumatol. 2009 Apr;23(2):161-92. [PMID: 19393565]
  • J Emerg Med. 2006 Apr;30(3):331-9. [PMID: 16677989]
  • Ann Rheum Dis. 2002 Jun;61(6):493-8. [PMID: 12006320]
  • Best Pract Res Clin Rheumatol. 2005 Jun;19(3):371-86. [PMID: 15939364]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757